ANDREW HULL - 15 Dec 2025 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull
Issuer symbol
INM
Transactions as of
15 Dec 2025
Net transactions value
$0
Form type
4
Filing time
17 Dec 2025, 12:20:20 UTC
Previous filing
03 Feb 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HULL ANDREW Director C/O INMED PHARMACEUTICALS INC., 1445-885 WEST GEORGIA ST., VANCOUVER, BRITISH COLUMBIA, CANADA /s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull 16 Dec 2025 0001818252

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -14 -1.4% $0.000000 961 15 Dec 2025 Common shares 14 $1397.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00